1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Sturlimogene Erparepvec: new trials by email Literature Review of Sturlimogene Erparepvec trials Research Report on Sturlimogene Erparepvec
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma | Phase 2 | Withdrawn | City of Hope Medical Center | 2026-08-11 | 2026-10-01 |
Carcinoma, Renal Cell (1) · Clear-cell metastatic renal cell carcinoma (1)
City of Hope Medical Center (1)
United States (1)
Charles B Nguyen (1)
P30CA033572 (1)